{
    "study_accession": "SDY474",
    "actual_completion_date": null,
    "actual_enrollment": 57,
    "actual_start_date": "2008-11-01",
    "age_unit": "Years",
    "brief_description": "This is a double-blind, multi-center, placebo controlled, Phase II study designed to assess biologic effects of 12 weeks of vitamin D3 supplementation on patients with well-controlled stable systemic lupus erythematosus who have low serum levels of 25-OH vitamin D and an IFN alpha signature.",
    "brief_title": "Vitamin D3 in Systemic Lupus Erythematosus (ALE02)",
    "clinical_trial": "Y",
    "condition_studied": "Systemic Lupus Erythematosus",
    "dcl_id": 2,
    "description": "This is a double-blind, multi-center, placebo controlled, Phase II study designed to assess biologic effects of 12 weeks of vitamin D3 supplementation on patients with well-controlled stable systemic lupus erythematosus who have low serum levels of 25-OH vitamin D and an IFN alpha signature.",
    "doi": "10.21430/M30T59MPBU",
    "endpoints": "The primary safety endpoint of this study is to measure the proportion of subjects in each study arm experiencing any adverse event > Grade 3 (NCI-CTCAE) over the duration of follow-up. This study is not designed to assess efficacy, but the impact of vitamin D repletion on clinical",
    "gender_included": "Female, Male",
    "hypothesis": "The proportion of subjects experiencing an IFN alpha signature response at Week 12 will be greater in the group supplemented with vitamin D3 compared to the group treated with placebo. A positive IFN alpha signature response for an individual is defined as a 50% decrease in expression of one IFN alpha responsive gene or a 25% decrease of two IFN alpha responsive genes, and no increase (of at least 25%) of the other IFN alpha inducible genes being assayed.",
    "initial_data_release_date": "2015-09-18",
    "initial_data_release_version": "DR15",
    "intervention_agent": "Vitamin D3",
    "latest_data_release_date": "2015-09-18",
    "latest_data_release_version": "DR15",
    "maximum_age": "  64.00",
    "minimum_age": "  18.00",
    "objectives": "The primary objective of this study is to explore the impact of vitamin D3 supplementation on the expression of an IFNalpha signature",
    "official_title": "ALE02 - Effect of Vitamin D3 on the IFN alpha Signature in Patients with Systemic Lupus Erythematosus",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 57,
    "workspace_id": 4040,
    "research_focus": [
        "Autoimmune"
    ],
    "arm": [
        {
            "arm_accession": "ARM2514",
            "description": "vitamin D3 4000 IU per day",
            "name": "4000 IU Vitamin D"
        },
        {
            "arm_accession": "ARM2515",
            "description": "vitamin D3 2000 IU per day",
            "name": "2000 IU Vitamin D"
        },
        {
            "arm_accession": "ARM2516",
            "description": "placebo",
            "name": "Placebo"
        }
    ],
    "personnel": [
        {
            "first_name": "Cynthia",
            "last_name": "Aranow",
            "organization": "Feinstein Institute for Medical Research NS-LIJ Health System",
            "role_in_study": "Principal Investigator",
            "site_name": "Feinstein Institute for Medical Research NS-LIJ Health System"
        }
    ],
    "pubmed": [
        {
            "title": "Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.",
            "journal": "Arthritis Rheumatol.",
            "month": "Jul",
            "year": "2015",
            "doi": "10.1002/art.39108.",
            "pubmed_id": "25777546"
        }
    ],
    "program": [
        {
            "program_name": "Autoimmunity Centers of Excellence (ACE) AI-12-060, AI-12-059",
            "contract_name": "EFFECT OF VITAMIN D3 ON THE IFNA SIGNATURE IN PATIENTS WITH LUPUS (ALE02)"
        }
    ],
    "assay": [
        {
            "measurement_technique": "Q-PCR",
            "number_of_expsamples": 162
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Asian",
                "count": 2
            },
            {
                "race": "Black or African American",
                "count": 32
            },
            {
                "race": "Other",
                "count": 3
            },
            {
                "race": "White",
                "count": 20
            }
        ],
        "gender": [
            {
                "Female": 54
            },
            {
                "Male": 3
            }
        ]
    }
}
